Announced

Completed

Morningside Ventures led a $17m Series A funding round in Neuroelectrics.

Synopsis

Morningside Ventures, a private equity firm, led a $17m Series A funding round in Neuroelectrics, a eveloper of non-invasive and high definition electrical brain stimulation technology designed for personalized neuromodulation. “By approaching disorders of the central nervous system using the natural signaling of the brain rather than focusing on one target and one receptor, we believe the Neuroelectrics approach could succeed in indications where traditional pharmaceuticals have had limited or no impact,” Stephen Bruso, Morningside.

Show Details & Financials

Did you work on this deal?

Claim Deal

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Claim Deal

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Morningside Ventures led a $17m Series A funding round in Neuroelectrics.